Primary Lung Cancer Treatment Guidelines (2022 Edition)

by Specialist

I. OverviewII. Screening and diagnosis
(A) Risk factors for lung cancer.
(B) Screening of high-risk groups.
(C) clinical presentation.
(iv) physical examination.
(V) Ancillary examinations.
Table 1 PET efficacy evaluation criteria for solid tumors (2009)
(F) pathological histological examination.
C. Pathological staging and staging of lung cancer
(a) World Health Organization 2021 histologic staging criteria for lung cancer.
(2)Staging of lung cancer.
IV. Treatment of lung cancer
(a) Surgical treatment.

    Surgical anatomy of the bronchial and pulmonary systems
  1. Optional indications for lung cancer surgery
  2. Contraindications to lung cancer surgery
  3. Concept of complete resection of lung cancer
  4. Lymph node dissection for lung cancer
  5. Overview of surgical procedures for lung cancer
  6. Surgical complications of lung cancer
  7. Advances in the surgical treatment of lung cancer

(ii) radiation therapy.

  1. Principles of radiotherapy
  2. Indications for radiotherapy for NSCLC
  3. Indications for radiotherapy for SCLC
  4. Prophylactic brain irradiation
  5. Patients with oligometastatic stage IV
  6. Palliative radiotherapy for patients with advanced lung cancer
  7. Treatment outcome
  8. Protection

(iii) drug therapy.
1. pharmacotherapy for advanced NSCLC
Table 2 Common first-line chemotherapy and chemotherapy combined with immunotherapy regimens for non-small cell lung cancerTable 3 Commonly used anti-vascular, immunotherapy, and targeted therapy agents for non-small cell lung cancer
Table 4 Common second-line treatment options for non-small-cell lung cancer
2. Drug therapy for non-surgically resectable NSCLC
3. Perioperative drug therapy for NSCLC
4. drug treatment for SCLC
5. principles of chemotherapy for lung cancer
(iv) bronchoscopic intervention.
(v) staging treatment modalities for non-small cell lung cancer.

  1. Comprehensive treatment for patients with stage I NSCLC
  2. Comprehensive treatment for patients with stage II NSCLC
  3. Comprehensive treatment for patients with stage III NSCLC
  4. Comprehensive treatment for patients with stage IV NSCLC

(vi) Stage treatment modalities for SCLC1. T1 to 2N0 localized stage SCLC
2. limited stage SCLC beyond T1 to 2N0
3. Extensive stage SCLC
(vii) Palliative care.
V. Prognosis
VI. Follow-up